Costs of chronic bronchitis and COPD: A 1-year follow-up study

Chest

Volumn 123, Issue 3, 2003, Pages 784-791

  Miravitlles, Marc ^a   Murio, Cristina ^b   Guerrero, Tina ^c   Gisbert, Ramon ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL GENERAL DE CATALUNYA   (Spain)

^c Pharma Consult Services SA   (Spain)

^d SOIKOS SL   (Spain)

Author keywords

Chronic bronchitis; COPD; Cost; Pharmacoeconomics; Primary care; Treatment primary care

Indexed keywords

ADULT; AGED; AIRWAY OBSTRUCTION; AMBULATORY CARE; ARTICLE; CALCULATION; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DATA ANALYSIS; DIAGNOSTIC TEST; DISEASE SEVERITY; DRUG COST; FEMALE; FOLLOW UP; GENERAL PRACTICE; HEALTH CARE COST; HEALTH VISITOR; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SPAIN;

EID: 0037336007     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.3.784     Document Type: Article

References (26)

1. Miravitlles M, Sobradillo V, Villasante C, et al. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): recruitment and field work [in Spanish]. Arch Bronconeumol 1999; 35:152-158
2. Sobradillo V, Miravitlles M, Gabriel R, et al. Geographical variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118:981-989
3. Jiménez-Ruiz CA, Masa F, Miravitlles M, et al. Smoking characteristics: attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119:1365-1370
4. Morbidity and mortality chartbook on cardiovascular, lung and blood diseases. Bethesda, MD: National Heart, Lung, and Blood Institute, May 1994
5. Rutten-van Mölken MPMH, Postma MJ, Joore MA, et al. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands. Respir Med 1999; 93:779-787
6. Jacobson L, Hertzman P, Löfdahl CG, et al. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991. Respir Med 2000; 94:247-255
7. Wilson L, Devine EB, So K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir Med 2000; 94:204-213
8. Morera J. Enfermedad pulmonar obstructiva crónica: magnitud del problema. In: Enfermedad pulmonar obstructiva crónica: conceptos generales. Vol 1. Barcelona, Spain: MCR Editions, 1992; 57-65
9. Strassels SA, Smith DH, Sullivan SD, et al. The cost of treating COPD in the United States. Chest 2001; 119:344-352
10. Hilleman DE, Dewan N, Malesker M, et al. Pharmacoeconomic evaluation of COPD. Chest 2000; 118:1278-1285
11. Miravitlles M, Murio C, Guerrero T. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis: DAFNE Study Group. Eur Respir J 2001; 17:928-933
12. Miravitlles M, Murio C, Guerrero T, et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121:1449-1455
13. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:S77-S120
14. Kesten S, Chapman KR. Physician perceptions and management of COPD. Chest 1993; 104:254-258
15. Eaton T, Withy S, Garrett JE, et al. Spirometry in primary care: the importance of quality assurance and the impact of spirometry workshops. Chest 1999; 116:416-423
16. Roca J, Sanchis J, Agustí-Vidal A, et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 1986; 22:217-217
17. Medicom SA. Vademecum internacional. Madrid, Spain: Medi Medic, 2000
18. Naberan Tond C. Survey on Barcelona health centre general practitioners' therapeutic attitude and control criteria of the patients with chronic respiratory diseases [in Spanish]. Aten Primaria 1994; 13:112-115
19. Miravitlles M, Murio C, Guerrero T, et al. Treatment of chronic bronchitis and COPD in primary care [in Spanish]. Arch Bronconeumol 1999; 35:173-178
20. O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000; 55:635-642
21. Stang P, Lydick E, Silberman C, et al. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000; 117(suppl):354S-359S
22. Miravitlles M, Mayordomo C, Artés M, et al. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med 1999; 93:173-179
23. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD): a consensus statement of the European Respiratory Society (ERS). Eur Respir J 1995; 8:1398-1420
24. British Thoracic Society. Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52(suppl 5):S1-S28
25. Barberá JA, Peces-Barba G, Agustí AGN, et al. Guidelines for diagnosis and treatment of chronic obstructive pulmonary disease [in Spanish]. Arch Bronconeumol 2001; 37:297-316
26. Serra-Batlles J, Plaza V, Morejón E, et al. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12:1322-1326